The ST2/IL-33 pathway is involved in many cardiovascular diseases, including ischemic and valvular heart disease, myocardial infarction (MI), heart failure (HF), myocarditis and cardiomyopathies. This evidence concerns the gene IL1RL1 and heart failure.